Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.

Lung cancer (Amsterdam, Netherlands) - 1 Jul 2007

Na Im Il, Rho Jin Kyung, Choi Yun Jung, Kim Cheol Hyeon, Park Jong Ho, Koh Jae Soo, Ryoo Baek-Yeol, Yang Sung Hyun, Lee Jae Cheol

Abstract excerpt

The aims of this study were to evaluate the prognostic implications of patients with epidermal growth factor receptor (EGFR) mutations and a p21 expression, and to determine their associations in resected non-small cell lung cancer (NSCLC) patients. We sequenced exons 18-21 of the EGFR tyrosine kinase domain by performing mutation analysis of tissues from patients that suffered with NSCLC and who also had...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Cyclin-Dependent Kinase Inhibitor p21

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Fluorescent Antibody Technique, Direct

Share to Microarray Analysis

Share to Neoplasm Staging

Share to Sex Factors

Share to Survival Analysis

Source

Identifiers

PMID: 17337084
DOI: 10.1016/j.lungcan.2007.01.027

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The survival outcomes of patients with resected non-small cell lung cancer differ according to EGFR mutations and the P21 expression.PMID 17337084Read ↗

Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.Semantic proximity Read ↗

Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer.Semantic proximity Read ↗

Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas.Semantic proximity Read ↗

Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancerSemantic proximity Read ↗

Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma.Semantic proximity Read ↗

Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.Semantic proximity Read ↗

Prognostic implication of EGFR mutation status and subtype in resected lung adenocarcinoma patients irrespective of therapy.Semantic proximity Read ↗

[Clinical characteristics and outcomes of lung cancer patients with EGFR mutations in exons 19 and 21].Semantic proximity Read ↗

Mutational Damages in Malignant Lung Tumors.Semantic proximity Read ↗

EGFR mutations as a prognostic and predictive marker in non-small-cell lung cancer.Semantic proximity Read ↗

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis.Semantic proximity Read ↗

Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.